Related Experiment Videos
[Pathological study of ER and PR in osteosarcoma]
1Department of Orthopaedics, Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|February 5, 2002
Summary
Estrogen receptor (ER) and progesterone receptor (PR) are present in osteosarcoma. Their expression levels correlate with the tumor
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Context:
- Osteosarcoma is a primary bone malignancy with diverse pathological features.
- Estrogen receptor (ER) and progesterone receptor (PR) are hormone receptors implicated in various cancers.
- Understanding receptor expression in osteosarcoma can provide insights into tumor biology and potential therapeutic targets.
Purpose:
- To investigate the association between ER and PR expression and the pathological characteristics of osteosarcoma.
- To determine if ER and PR levels correlate with tumor grade and type in osteosarcoma patients.
Summary:
- Immunohistochemical analysis of 65 osteosarcoma tissue samples revealed ER positivity in 40% and PR positivity in 32.3%.
- ER and PR expression showed a statistically significant positive correlation with higher cell differentiation grades.
- No significant relationship was found between ER/PR expression and the pathological type of osteosarcoma.
Impact:
- Estrogen receptor and progesterone receptor are present in osteosarcoma tissues.
- ER and PR expression levels are linked to the degree of cellular differentiation in osteosarcoma.
- These findings contribute to understanding the molecular landscape of osteosarcoma and may inform future research into receptor-targeted therapies.